Catalyst Wire Dossier Catalyst Wire Dossier

Betamethasone Dipropionate USP, 0.05%

betamethasone dipropionate · TruPharma LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Betamethasone Dipropionate USP, 0.05%, covering 2022-02-18 to 2022-02-18. Get the full timeline:

Most recent: FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)

See pricing